Related Experiment Videos
Nitric oxide mechanisms in migraine
1Department of Neurology, Glostrup Hospital, University of Copenhagen, Denmark.
Pathologie-Biologie
|November 10, 2000
Summary
Nitric oxide (NO) may be a key molecule in triggering migraine pain. Inhibiting NO synthase has shown effectiveness in treating acute migraine attacks, suggesting new treatment avenues.
Area of Science:
- Neuroscience
- Pharmacology
- Vascular Biology
Background:
- Migraine pain mechanisms remain unclear, with neurogenic inflammation proposed but lacking direct evidence.
- Existing neurotransmitters implicated in neurogenic inflammation do not fully explain migraine headache.
- Previous studies suggest nitric oxide (NO) as a potential mediator of headache.
Purpose of the Study:
- To review the biological role of nitric oxide (NO).
- To examine scientific evidence linking NO to migraine headache.
- To propose NO release as a molecular trigger for spontaneous migraine pain.
Main Methods:
- Literature review of NO biology and its role in headache.
- Analysis of evidence from glyceryl trinitrate and histamine infusion studies.
- Examination of findings from nitric oxide synthase (NOS) inhibitor trials.
Main Results:
- Nitric oxide (NO) is a small messenger molecule with significant biological functions.
- Evidence suggests NO release from various sources (blood vessels, nerves, brain tissue) may initiate migraine pain.
- Intravenous infusion of a nitric oxide synthase (NOS) inhibitor effectively treated acute migraine attacks.
Conclusions:
- Nitric oxide (NO) is a strong candidate molecule involved in the molecular mechanism of migraine.
- The hypothesis of NO-induced migraine pain is supported by recent therapeutic findings.
- Inhibition of NO synthesis presents a promising new strategy for migraine treatment.